Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Doxycycline: An essential tool for Alzheimer’s disease

13 May 2025

Abstract excerpt

The identification of active interventions in neurodegenerative disorders is a major challenge in neurology; the use of repurposed drugs may represent a valuable strategy. Tetracyclines, a second generation of antibiotic molecules, offer various potential applications. Following an anecdotal observation of the potential anti-amyloidogenic activity of iododoxorubicin, the search for chemical analogs with a better...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Neuroinflammation and Neurodegeneration Mechanisms
Share to Prion Diseases and Protein Misfolding

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40367557
DOI: 10.1016/j.biopha.2025.118159

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Doxycycline: An essential tool for Alzheimer’s diseasePMID 40367557Read ↗

The Anti-Amyloidogenic Action of Doxycycline: A Molecular Dynamics Study on the Interaction with Aβ42Semantic proximity Read ↗

Testing the Therapeutic Potential of Doxycycline in a Drosophila melanogaster Model of Alzheimer DiseaseSemantic proximity Read ↗

Approaches for discovering anti-prion compounds: lessons learned and challenges ahead.Semantic proximity Read ↗

Minocycline for Huntington’s disease: An open label studySemantic proximity Read ↗

Minocycline inhibits cell death and decreases mutant Huntingtin aggregation by targeting Apaf-1.Semantic proximity Read ↗

The history of the tetracyclinesSemantic proximity Read ↗

Molecular mechanisms of 10-Butyl Ether Minocycline (BEM), a novel non-antibiotic tetracycline, as a potential treatment for inflammatory and neuroimmune-related disordersSemantic proximity Read ↗

Targeting Amyloid Aggregation: An Overview of Strategies and MechanismsSemantic proximity Read ↗

Minocycline as a potential therapeutic agent in neurodegenerative disorders characterized by protein misfoldingSemantic proximity Read ↗

Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model.Semantic proximity Read ↗

State of the Globe: Doxycycline - An Old Wine in a New Bottle for Gram-Negative SepsisSemantic proximity Read ↗

A Case of COVID-19 Successfully Treated with Minocycline and Saiko-Keishi-ToSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.